Foresite Capital Management III

Latest statistics and disclosures from Foresite Capital Management III's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are ASND, VRNA, NTRA, Cymabay Therapeutics, and represent 100.00% of Foresite Capital Management III's stock portfolio.
  • Foresite Capital Management III has $38M in assets under management (AUM), dropping by 37.41%.
  • Central Index Key (CIK): 0001645157

Tip: Access up to 7 years of quarterly data

Positions held by Foresite Capital Management III consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Foresite Capital Management III

Foresite Capital Management III holds 4 positions in its portfolio as reported in the September 2022 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Ascendis Pharma A/S Sponsored Ads (ASND) 36.4 $14M 134k 103.26
 View chart
Verona Pharma Sponsored Ads (VRNA) 30.0 $11M 1.1M 10.22
 View chart
Natera (NTRA) 18.4 $7.0M 159k 43.82
 View chart
Cymabay Therapeutics 15.2 $5.7M 1.6M 3.50
 View chart

Past Filings by Foresite Capital Management III

SEC 13F filings are viewable for Foresite Capital Management III going back to 2015

View all past filings